Ameriprise’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-227,609
Closed -$289K 4017
2024
Q4
$289K Buy
227,609
+168,134
+283% +$214K ﹤0.01% 3714
2024
Q3
$203K Buy
59,475
+21,766
+58% +$74.2K ﹤0.01% 3737
2024
Q2
$176K Buy
37,709
+5,933
+19% +$27.7K ﹤0.01% 3707
2024
Q1
$236K Sell
31,776
-6,694
-17% -$49.7K ﹤0.01% 3649
2023
Q4
$390K Buy
38,470
+25,254
+191% +$256K ﹤0.01% 3539
2023
Q3
$103K Sell
13,216
-6,034
-31% -$47.1K ﹤0.01% 3795
2023
Q2
$158K Sell
19,250
-39,240
-67% -$323K ﹤0.01% 3759
2023
Q1
$424K Sell
58,490
-135,769
-70% -$984K ﹤0.01% 3486
2022
Q4
$1.72M Sell
194,259
-6,275
-3% -$55.7K ﹤0.01% 2875
2022
Q3
$2.45M Buy
200,534
+154,906
+339% +$1.9M ﹤0.01% 2689
2022
Q2
$539K Sell
45,628
-1,588
-3% -$18.8K ﹤0.01% 3367
2022
Q1
$898K Sell
47,216
-5,297
-10% -$101K ﹤0.01% 3256
2021
Q4
$1.4M Buy
52,513
+17,144
+48% +$456K ﹤0.01% 3101
2021
Q3
$1.45M Sell
35,369
-13,862
-28% -$569K ﹤0.01% 2993
2021
Q2
$2.79M Buy
49,231
+12,249
+33% +$694K ﹤0.01% 2769
2021
Q1
$1.55M Buy
36,982
+11,639
+46% +$489K ﹤0.01% 2946
2020
Q4
$1.67M Buy
25,343
+14,294
+129% +$944K ﹤0.01% 2869
2020
Q3
$309K Sell
11,049
-3,010
-21% -$84.2K ﹤0.01% 3412
2020
Q2
$414K Sell
14,059
-8,322
-37% -$245K ﹤0.01% 3254
2020
Q1
$444K Sell
22,381
-29,626
-57% -$588K ﹤0.01% 3170
2019
Q4
$1.54M Sell
52,007
-19,109
-27% -$566K ﹤0.01% 2862
2019
Q3
$1.62M Buy
71,116
+17,522
+33% +$398K ﹤0.01% 2798
2019
Q2
$1.33M Sell
53,594
-11,114
-17% -$275K ﹤0.01% 2943
2019
Q1
$1.58M Buy
64,708
+15,865
+32% +$388K ﹤0.01% 2847
2018
Q4
$1.11M Sell
48,843
-5,827
-11% -$133K ﹤0.01% 2896
2018
Q3
$1.74M Buy
54,670
+21,097
+63% +$671K ﹤0.01% 2861
2018
Q2
$1.2M Buy
33,573
+13,769
+70% +$493K ﹤0.01% 2944
2018
Q1
$580K Buy
+19,804
New +$580K ﹤0.01% 3159